[Treatment of osteoporosis--a new paradigm].
Shiraki
Masataka
M
Research Institute and Practice for Involutional Diseases.
D019386:Alendronate; D015519:Bone Density; D002762:Cholecalciferol; D004164:Diphosphonates / Q000627:therapeutic use; D015195:Drug Design; D050723:Fractures, Bone / Q000209:etiology / Q000517:prevention & control; D006801:Humans; D010024:Osteoporosis / Q000175:diagnosis / Q000628:therapy*; D010281:Parathyroid Hormone; D012015:Reference Standards; D012306:Risk; D020845:Selective Estrogen Receptor Modulators; D013324:Strontium
D004164:Diphosphonates; D010281:Parathyroid Hormone; D020845:Selective Estrogen Receptor Modulators; D002762:Cholecalciferol; D019386:Alendronate; D013324:Strontium